Skip to main content
Premium Trial:

Request an Annual Quote

Anna Astriab-Fisher, Steven Paul

Premium
Anna Astriab-Fisher has been named vice president of assay development at GenTel BioSciences, the Madison, Wis.-based protein-array company said last week.

Prior to joining GenTel, Astriab-Fisher worked in the technology-development department of GlaxoSmithKline where she specialized in immunoassay protocols.


Sigma-Aldrich's board of directors elected Steven Paul to be a company director, Sigma said last week.
 
Paul currently is executive vice president for science and technology and president of the Lilly Research Laboratories of Eli Lilly.
 
Before working at Eli Lilly, Paul served as scientific director of the National Institutes of Health.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.